Bionano Genomics, Inc.9540 Towne Centre Drive, Suite 100
San Diego, California 92121
(858) 888-7600
August 21, 2020
Via Edgar
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Jeffrey Gabor
| Re: | Bionano Genomics, Inc. |
| | Registration Statement on Form S-3 |
| | File No. 333-245762 |
Ladies and Gentlemen:
Bionano Genomics, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective at 4:00 p.m. Eastern Time on Tuesday, August 25, 2020, or as soon thereafter as is practicable. The Registrant also hereby requests a copy of the written order verifying the effective date.
If you have any questions regarding this request, please contact James Pennington of Cooley LLP at (858) 550-6029.
Sincerely,
Bionano Genomics, Inc.
| By: | /s/ R. Erik Holmlin, Ph.D. | |
| | R. Erik Holmlin, Ph.D. | |
| | President and Chief Executive Officer | |
| | | |
| cc: | James Pennington, Cooley LLP | |
